1K. Haraguchi,H. Shimura,T. Onaya. Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)γ activators[J] 2003,Clinical and Experimental Nephrology(1):0027～0032
2S. Kumar,Prof. A. J. M. Boulton,H. Beck-Nielsen,F. Berthezene,M. Muggeo,B. Persson,G. A. Spinas,S. Donoghue,S. Lettis,P. Stewart-Long. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients[J] 1996,Diabetologia(6):701～709
